Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$7.33 - $9.4 $798 - $1,024
109 Added 5.19%
2,209 $20,000
Q1 2022

May 13, 2022

SELL
$7.97 - $9.85 $8,496 - $10,500
-1,066 Reduced 33.67%
2,100 $17,000
Q4 2021

Feb 15, 2022

BUY
$8.85 - $10.42 $28,019 - $32,989
3,166 New
3,166 $30,000

Others Institutions Holding PROC

About Procaps Group, S.A.


  • Ticker PROC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 112,824,000
  • Market Cap $196M
  • Description
  • Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...
More about PROC
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.